Enovis CORP (ENOV) Financial Statements (2026 and earlier)

Company Profile

Business Address 2711 CENTERVILLE ROAD
WILMINGTON, DE 19808
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3842 - Orthopedic, Prosthetic, and Surgical Appliances and Supplies (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2025
Q3
6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments44,07438,46048,16735,42535,00466,267
Cash and cash equivalent44,07438,46048,16735,42535,00466,267
Receivables453,702435,618407,031400,216394,736381,053
Inventory, net of allowances, customer advances and progress billings628,215585,911547,120609,665615,037586,002
Inventory628,215585,911547,120609,665615,037586,002
Prepaid expense43,77542,49436,24645,58740,55036,033
Asset, held-for-sale, not part of disposal group      
Other current assets110,585115,698107,882112,17287,42681,364
Total current assets:1,280,3511,218,1811,146,4461,203,0651,172,7531,150,719
Noncurrent Assets
Operating lease, right-of-use asset65,18365,94968,91563,38768,24370,146
Property, plant and equipment460,130426,288404,500403,250378,449345,701
Intangible assets, net (including goodwill)3,123,3213,077,8813,010,1383,790,1193,733,9343,822,921
Goodwill1,781,3261,733,3341,692,7092,393,6912,353,4562,414,611
Intangible assets, net (excluding goodwill)1,341,9951,344,5471,317,4291,396,4281,380,4781,408,310
Other noncurrent assets92,41386,73588,77890,32088,64989,194
Total noncurrent assets:3,741,0473,656,8533,572,3314,347,0764,269,2754,327,962
TOTAL ASSETS:5,021,3984,875,0344,718,7775,550,1415,442,0285,478,681
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities548,155457,395508,971510,193502,977529,031
Accounts payable212,016188,149179,098158,037159,832155,748
Accrued liabilities336,139269,246329,873352,156343,145373,283
Debt20,02920,02820,02720,02915,02820,101
Disposal group, including discontinued operation      
Total current liabilities:568,184477,423528,998530,222518,005549,132
Noncurrent Liabilities
Long-term debt and lease obligation1,373,5101,367,5371,309,4731,325,4401,329,4271,318,463
Long-term debt, excluding current maturities1,373,5101,367,5371,309,4731,325,4401,329,4271,318,463
Liabilities, other than long-term debt450,559360,695263,516313,760255,203249,054
Other liabilities450,559360,695263,516313,760255,203249,054
Other undisclosed noncurrent liabilities48,18549,16152,46147,42050,45551,190
Total noncurrent liabilities:1,872,2541,777,3931,625,4501,686,6201,635,0851,618,707
Total liabilities:2,440,4382,254,8162,154,4482,216,8422,153,0902,167,839
Equity
Equity, attributable to parent2,578,1872,617,7682,562,2623,330,4163,286,4143,308,427
Common stock575756565555
Additional paid in capital3,031,0933,021,6902,973,1212,964,9972,911,2542,903,277
Accumulated other comprehensive loss(77,235)(64,990)(127,892)(54,951)(76,730)(65,378)
Retained earnings (accumulated deficit)(375,728)(338,989)(283,023)420,314451,835470,473
Equity, attributable to noncontrolling interest2,7732,4502,0672,8832,5242,415
Total equity:2,580,9602,620,2182,564,3293,333,2993,288,9383,310,842
TOTAL LIABILITIES AND EQUITY:5,021,3984,875,0344,718,7775,550,1415,442,0285,478,681

Income Statement (P&L) ($ in thousands)

9/30/2025
Q3
6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
Revenues564,545558,834560,975505,222525,160516,266
Cost of revenue
(Cost of Product and Service Sold)
(229,848)(226,605)(253,457)(218,763)(236,277)(218,370)
Gross profit:334,697332,229307,518286,459288,883297,896
Operating expenses(341,452)(339,359)(157,007)(318,196)(333,102)(319,999)
Other undisclosed operating loss (10,041)(39,639)(815,260)  (12,911)
Operating loss:(16,796)(46,769)(664,749)(31,737)(44,219)(35,014)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
436(1,392)9220233,836(24,235)
Interest and debt expense     (16,969)(19,996)
Loss from continuing operations before equity method investments, income taxes:(16,360)(48,161)(664,657)(31,535)(27,352)(79,245)
Other undisclosed loss from continuing operations before income taxes(9,294)(9,188)(9,069)(11,066)  
Loss from continuing operations before income taxes:(25,654)(57,349)(673,726)(42,601)(27,352)(79,245)
Income tax expense (benefit)(10,801)1,769(29,900)9,0968,9087,404
Loss from continuing operations:(36,455)(55,580)(703,626)(33,505)(18,444)(71,841)
Income (loss) from discontinued operations(93)(125)4262,243(68) 
Net loss:(36,548)(55,705)(703,200)(31,262)(18,512)(71,841)
Other undisclosed net loss attributable to parent(191)(261)(137)(259)(126)(157)
Net loss available to common stockholders, diluted:(36,739)(55,966)(703,337)(31,521)(18,638)(71,998)

Comprehensive Income ($ in thousands)

9/30/2025
Q3
6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
Net loss:(36,548)(55,705)(703,200)(31,262)(18,512)(71,841)
Other comprehensive income (loss)(12,113)63,024(73,144)21,879(11,369)(40,548)
Comprehensive income (loss):(48,661)7,319(776,344)(9,383)(29,881)(112,389)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(323)(383)645(359)(109)(106)
Comprehensive income (loss), net of tax, attributable to parent:(48,984)6,936(775,699)(9,742)(29,990)(112,495)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: